Cleveland Clinic Lerner Research Institute Logo
Cleveland Clinic Lerner Research Institute Logo
  • About
  • Science
    • Laboratories
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Microbiome & Human Health
      Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • Ohio
      3D Printing BioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Immunology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering Flow Cytometry
      Genomic Medicine Institute Biorepository Genomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic Lerner Research Institute BioRepository
      Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions
      Technical & Administrative
  • Donate
  • Contact
  • About
  • Science
    • Scientific Programs
    • Laboratories
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Microbiome & Human Health
      Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • All Cores
    • Ohio
      3D Printing BioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Immunology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering Flow Cytometry
      Genomic Medicine Institute BiorepositoryGenomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic Lerner Research Institute BioRepository
      Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Research Education & Training Center
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions
      Technical & Administrative
  • Donate
  • Contact
  • Search

Research News

❮News FDA Recognizes PTEN Variant Criteria

01/03/2019

FDA Recognizes PTEN Variant Criteria


Recently, for the first time, the FDA formally recognized the process that led to curation of a public database containing information about genes, gene variants and their relationship to disease as a source of valid scientific evidence that can be used to support clinical validity in premarket submissions. Among the gene variants listed in this database are variants of PTEN, a highly penetrant cancer susceptibility gene.

The Database

Known as ClinVar, the database was funded by the National Institutes of Health and curated by teams of more than 700 genetics experts who make up the Clinical Genome Resource (ClinGen) consortium. The ClinGen consortium’s work encourages sharing expertly curated and interpreted data on genetic variants, permitting developers to point to the genetic information available in the database to support the clinical validity of their tests, rather than gathering their own data, thus saving time and money.

Prior to this advancement, data about genetic variants were not always accessible, or were widely accessible but without uniform curation. A genetic database is a collection of research-generated information about genetic differences that, once organized, documents the evidence supporting links between a human genetic variant and a particular disease or condition. This information can be useful to researchers and developers, reducing regulatory hurdles in test development and spurring advancements in precision medicine. ClinVar differs from other databases because it is curated by experts from multiple institutions using systematic review procedures, is open to the public, and the FDA considers it a source of scientific evidence. This curation process is the first that is FDA approved.

Developing PTEN-Specific Criteria for the ClinVar Database

For some genes or disorders, expert variant curation groups already existed; however, for other genes, such as PTEN, expert panels had not yet been formed. In order to develop specifications to the Sequence Variant Interpretations Guidelines set forth in 2015 by the American College of Medical Genetics and the Association for Molecular Pathology for PTEN variants, a ClinGen PTEN Expert Panel was formed. Charis Eng, MD, PhD, founding chair of Cleveland Clinic’s Genomic Medicine Institute, co-chaired the panel.

In a recent article, the ClinGen PTEN Expert Panel described the finalized criteria for PTEN-specific variant classification and the outcomes of applying the criteria to a pilot group of 42 variants with benign/likely benign (BEN/LBEN), pathogenic/likely pathogenic (PATH/LPATH), uncertain significance (VUS) and conflicting (CONF) ClinGen assertions. Applying the PTEN Exert Panel criteria to the BEN/LBEN and PATH/LPATH led to an overall concordance of 96.8%. When applying these rules to six VUS and two CONF variants, with some additional data from a shared internal library, one VUS was reclassified as LBEN and two CONF variants were reclassified as PATH and LPATH.

One of PTEN's roles in the body is as a tumor suppressor gene, which means that when it works correctly, PTEN helps slow or prevent growth of pro-cancer cells that may develop into tumors. Receiving a result of VUS or CONF can present clinical challenges, as genetic findings are often used in surgical decision-making and to determine a patient’s cancer surveillance protocol. Dr. Eng states, “FDA recognition of the PTEN Expert Panel’s assertions means that cancers may be found earlier, and perhaps even prevented, in some patients.”

Featured Experts

Charis Eng Headshot

Charis Eng, MD, PhD

Department Chair
Sondra J. and Stephen R. Hardis Endowed Chair in Cancer Genomic Medicine
Lab Profile

Related News Articles

...
Not All Mutations are Bad: Researchers Identify Differences between Benign and Pathogenic Variants

Dr. Lal’s team conducted the first big data characterization of missense variants from 1,300 disease-associated genes to identify features associated with pathogenic and benign variants.

...
Collaboration with CDC Uncovers Genetic Risk for Foodborne Disease

...
Researchers to Study Genetics of Focal Cortical Dysplasia with New NIH Grant

Dr. Lal’s team will perform the most comprehensive genetic analysis of focal cortical dysplasia (FCD) to confirm proposed FCD-associated genes and identify novel FCD causal genes and variants.

Want To Support Ground-Breaking Research at Cleveland Clinic?

Discover how you can help Cleveland Clinic save lives and continue to lead the transformation of healthcare.

Give to Cleveland Clinic

Subscribe to get the latest research news in your inbox.

About Lerner

About Us Careers Contact Us Donate People Directory

Science

Clinical & Translational Research Core Services Departments, Centers & Programs Laboratories Research News

Education & Training

Graduate Programs Molecular Medicine PhD Program Postdoctoral Program RISE Program Undergraduate & High School Programs

Site Information & Policies

Search Site Site Map Privacy Policy Social Media Policy

9500 Euclid Avenue, Cleveland, Ohio 44195 | © 2023 Lerner Research Institute